130
Participants
Start Date
September 30, 2025
Primary Completion Date
September 30, 2030
Study Completion Date
September 30, 2030
Neuropsychological assessments:
"Several neuropsychological assessments were carried out during the study (at inclusion and 2 years after inclusion), consisting of :~* parental questionnaires (standard questionnaires and questionnaires specifically drawn up for the trial). The aim of these questionnaires will be to assess the patient's neurocognitive level at different times (before and after radiotherapy treatment).~* patient cognitive tests (½ day face-to-face consultation/assessment with a neuropsychologist specialising in paediatrics, followed by a 30-minute telephone call).~Only for patients having received their radiotherapy treatment at the IUCT-O: a multimodal MRI specific to the study (without injection of contrast product) may be performed at inclusion and 2 years after inclusion."
CHU Angers, Angers
CHU de Bordeaux, Bordeaux
Centre François Baclesse, Caen
Centre Georges François Leclerc, Dijon
Centre Oscar Lambret, Lille
Centre Léon Bérard, Lyon
APHM - Hôpital la Timone, Marseille
Institut du Cancer de Montpellier, Montpellier
Centre Antoine Lacassagne, Nice
Institut Curie, Paris
Centre Eugène Marquis, Rennes
Institut de Cancérologie de l'Ouest, Saint-Herblain
ICANS, Strasbourg
IUCT-O, Toulouse
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy
Institut Gustave Roussy, Villejuif
Institut Claudius Regaud
OTHER